Ginkgo Datapoints is the Bio × AI data provider for drug discovery. A Ginkgo Bioworks business, Datapoints generates AI-ready data across Antibody Developability, Perturbation Response Profiling, Specialized HTS, and Small Molecule ADME — all through validated, automated workflows. Since launching in Q4 2024, we've worked with 10 of the top 20 pharma companies and many others across the biotech, tech, and academic landscape. Your thought-partner, modeler, and data generator for the Bio × AI era.